Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical Isolates. (2016)
Attributed to:
Accelerating discovery science to clinical translation: CiC3 - The Oxford MRC CiC Pipeline
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1128/aac.00371-16
PubMed Identifier: 27139464
Publication URI: http://europepmc.org/abstract/MED/27139464
Type: Journal Article/Review
Volume: 60
Parent Publication: Antimicrobial agents and chemotherapy
Issue: 7
ISSN: 0066-4804